Iatrogenic hypokalaemia.
Haboubi
N Y
NY
Barford
A V
AV
Asquith
P
P
D000368:Aged; D000464:Alginates / Q000009:adverse effects*; D000536:Aluminum Hydroxide / Q000009:adverse effects*; D001639:Bicarbonates / Q000009:adverse effects*; D002229:Carbenoxolone / Q000009:adverse effects*; D004338:Drug Combinations / Q000009:adverse effects; D006034:Glycyrrhetinic Acid / Q000031:analogs & derivatives*; D006801:Humans; D007008:Hypokalemia / Q000139:chemically induced*; D008297:Male; D017640:Silicates; D012824:Silicic Acid / Q000009:adverse effects*; D012822:Silicon Dioxide / Q000009:adverse effects*
D000464:Alginates; D001639:Bicarbonates; D004338:Drug Combinations; D017640:Silicates; D012824:Silicic Acid; D000536:Aluminum Hydroxide; D012822:Silicon Dioxide; C021080:pyrogastrone; D002229:Carbenoxolone; D006034:Glycyrrhetinic Acid